Glaxo to Invest Up to $1 Billion in CureVac Vaccine Pact

Bookmark
(Bloomberg) -- GlaxoSmithKline Plc agreed to work with Germany’s CureVac on as many as five novel mRNA vaccines that will target infectious diseases as Covid-19 prompts companies and governments to...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.